Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Depreciation & Amortization (CF): 2010-2025

Historic Depreciation & Amortization (CF) for Cumberland Pharmaceuticals (CPIX) over the last 15 years, with Sep 2025 value amounting to $1.0 million.

  • Cumberland Pharmaceuticals' Depreciation & Amortization (CF) fell 7.01% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year decrease of 0.86%. This contributed to the annual value of $4.9 million for FY2024, which is 0.68% down from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Depreciation & Amortization (CF) stood at $1.0 million for Q3 2025, which was up 0.38% from $1.0 million recorded in Q2 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Depreciation & Amortization (CF) peaked at $1.7 million during Q1 2022, and registered a low of $511,483 during Q4 2022.
  • Over the past 3 years, Cumberland Pharmaceuticals' median Depreciation & Amortization (CF) value was $1.2 million (recorded in 2024), while the average stood at $1.2 million.
  • Per our database at Business Quant, Cumberland Pharmaceuticals' Depreciation & Amortization (CF) crashed by 52.51% in 2022 and then skyrocketed by 141.12% in 2023.
  • Quarterly analysis of 5 years shows Cumberland Pharmaceuticals' Depreciation & Amortization (CF) stood at $1.1 million in 2021, then tumbled by 52.51% to $511,483 in 2022, then soared by 141.12% to $1.2 million in 2023, then rose by 21.34% to $1.5 million in 2024, then fell by 7.01% to $1.0 million in 2025.
  • Its Depreciation & Amortization (CF) was $1.0 million in Q3 2025, compared to $1.0 million in Q2 2025 and $1.0 million in Q1 2025.